Clinical Trial Update: COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

The COPPER trial evaluating copper-based products for Incontinence-associated Dermatitis has been withdrawn from Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incontinence-associated Dermatitis

Drugs mentioned

• Copper-based products (copper-based product)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Incontinence-associated Dermatitis | Phase 2, Phase 3 | Status: WITHDRAWN